Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Opis bibliograficzny
1. autor:	Zangmo, Thinley
Kolejni autorzy:	Asaduzzaman, Muhammad
Format:	Praca dyplomowa
Język:	English
Wydane:	Brac University 2024
Hasła przedmiotowe:	Lung cancer NF-kB pathway SNP Co-expressed genes Differentially expressed genes Lungs > Cancer > Treatment. Lungs > Cancer > Molecular aspects. Bioinformatics.
Dostęp online:	http://hdl.handle.net/10361/24297

Podobne zapisy

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
od: Razna, Amrin Islam
Wydane: (2019)

Molecules associated with the development of lung cancer
od: Rahman, Adree, i wsp.
Wydane: (2023)

Protein biomarkers for Lung Cancer: a bioinformatic approach
od: Jeba, Joynob
Wydane: (2017)

A review on targeted therapies for lung cancer
od: Ashraf, Anushey
Wydane: (2023)

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Wydane: (2023)

A review on recent advances in drugs for lung cancer treatment
od: Noor, Fouzia
Wydane: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Wydane: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Wydane: (2021)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Wydane: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Wydane: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Wydane: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
od: Shabnam, Musharrat
Wydane: (2018)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Wydane: (2023)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Wydane: (2024)

Immunotherapy in the Management of Lung Cancer
od: Tasnim, Humayra
Wydane: (2022)

Qualitative classification of the breast cancer genome and clustering of the cancer gene network
od: Fatema, Kaniz, i wsp.
Wydane: (2019)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
od: Das, Reshita
Wydane: (2024)

A study of glioblastoma gene profile
od: Nabila, Nusrat Jahan
Wydane: (2024)

Lung cancer detection and classification using machine learning
od: Arefin, Mahbubul, i wsp.
Wydane: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
od: Beruni, Sajid Mahmud Al
Wydane: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
od: Mukti, Roushney Fatima, i wsp.
Wydane: (2016)

A study of Osteosarcoma gene profile
od: Arka, Sadib Md.
Wydane: (2022)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
od: Nuha, Nabiha Tahsin
Wydane: (2024)

Role of statins as antagonists of SPARC in gastric cancer
od: Shahmat, Rad
Wydane: (2019)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
od: Nandy, Aditi
Wydane: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Wydane: (2024)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Karim, Samia Binte
Wydane: (2024)

Pathway analysis of Disease-Gene associated network in the human breast cancer
od: Lamia
Wydane: (2020)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
od: Shaikat, Mahdi Mubin
Wydane: (2023)

To control site-specific skin gene expression, autocrine mimics paracrine canonical Wnt signaling and Is activated ectopically in skin disease
od: Kim, Dongwon, i wsp.
Wydane: (2016)

Oncogenes: new targets in cancer treatment
od: Chowdhury, Waseka Shams
Wydane: (2020)

A review on RNAi technology and its therapeutic potential in Cancer
od: Mahaleka, Aarshi
Wydane: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
od: Ahmed, Nafisa
Wydane: (2023)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
od: Araf, Faiaz Fahim
Wydane: (2024)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
od: F. S. Amaral, André, i wsp.
Wydane: (2017)

Identification of the multi-drug resistant genes in the bacteria isolated from the saliva of smoker oral cancer patients and comparative analysis with smoker normal individuals
od: Hasan, Samir, i wsp.
Wydane: (2024)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
od: Auvy, Akib Al Mahmud, i wsp.
Wydane: (2023)

Statistics and informatics in molecular cancer research

A review on potential of PARP inhibitors in the treatment of prostate cancer
od: Islam, Saidul
Wydane: (2022)

A review on triple-negative breast cancer and its potential treatment
od: Niasa, Jannatul Ferdous
Wydane: (2023)